Clinical trial
UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving…
NCT00064272 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00064272 |
|---|---|
| Title | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer |
| Official title | Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting AKA IRB 2003-213 |
| Acronym | IRB 2003-551 |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH National Center for Complementary and Integrative Health (NCCIH) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | ginger extract, placebo |
| Enrollment | 180 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2007 |
| First posted | Jul 9, 2003 |
| Last update posted | Oct 21, 2016 |
| Countries | Puerto Rico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: